Results 101 to 110 of about 3,460 (196)

Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements [PDF]

, 2017
We studied a community cohort of 193 individuals exposed to endemic Schistosoma japonicum infection in the Dongting Lake region of China to assess subclinical morbidity and the 2-year benefit of curative therapy (praziquantel) administered in 1996 ...
Li, Y., Li, Y.S., McManus, D.P., Ross, A.G.P., Sleigh, A.C., Tanner, M., Williams, G.M.   +6 more
core  

Assessment of the age-specific disability weight of chronic schistosomiasis japonica

Bulletin of the World Health Organization, 2007
OBJECTIVE: To estimate the age-specific disability weight of chronic schistosomiasis japonica in China. METHODS: Between October 2004 and January 2005, residents from two schistosome-endemic counties were screened for Schistosoma japonicum infection ...
Tie-Wu Jia, Xiao-Nong Zhou, Xian-Hong Wang, Jürg Utzinger, Peter Steinmann, Xiao-Hua Wu   +5 more
doaj  

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica. [PDF]

Sci Rep, 2023
Yang Y, Wang XY, Duan C, Wang ZJ, Sheng HY, Xu XL, Wang WJ, Yang JH.   +7 more
europepmc   +1 more source

Comparative assessment of the SjSAP4-incorporated gold immunochromatographic assay for the diagnosis of human schistosomiasis japonica. [PDF]

Front Public Health, 2023
Mu Y, Rivera J, McManus DP, Weerakoon KG, Ross AG, Olveda RM, Gordon CA, You H, Jones MK, Cai P.   +9 more
europepmc   +1 more source

Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China [PDF]

, 2017
We report the 5-year impact (1996-2001) of repeated praziquantel chemotherapy on subclinical morbidity related to Schistosoma japonicum infection. We repeated stool examinations and hepatosplenic ultrasonography in a cohort of 120 individuals living on ...
Dessein, A., Li, Y., Li, Y.S., McManus, D.P., Sleigh, A.C., Tanner, M., Williams, G.M.   +6 more
core  

Schistosoma japonicum Tyrosine Hydroxylase is promising targets for immunodiagnosis and immunoprotection of Schistosomiasis japonica. [PDF]

PLoS Negl Trop Dis, 2023
Piao X, Duan J, Jiang N, Liu S, Hou N, Chen Q.   +5 more
europepmc   +1 more source

Estimating and modeling the dynamics of the intensity of infection with Schistosoma japonicum in villagers of Leyte, Philippines. Part II: Intensity-specific transmission of S. japonicum. The schistosomiasis transmission and ecology project [PDF]

, 2005
A dynamic model of Schistosoma japonicum transmission is presented that incorporates effects of infection intensity, age, and sex. We use four infection intensity classes to investigate the impact of ecologic changes and public health interventions on ...
Carabin, H, Marshall, C, McGarvey, ST, Olveda, R, Riley, S, Willingham, AL   +5 more
core  

Development and assessment of a novel gold immunochromatographic assay for the diagnosis of schistosomiasis japonica. [PDF]

Front Immunol, 2023
Mu Y, McManus DP, Gordon CA, You H, Ross AG, Olveda RM, Cai P.   +6 more
europepmc   +1 more source

Knocking Down Gm16685 Decreases Liver Granuloma in Murine Schistosomiasis Japonica. [PDF]

Microorganisms, 2023
Zhao R, Tang X, Lin H, Xing C, Xu N, Dai B, Wang P, Shao W, Liu M, Shen J, Deng S, Ren C.   +11 more
europepmc   +1 more source

Diagnostic Efficacy of Plasma-Based Real-Time PCR for Schistosomiasis Japonica in Mice before and after Treatment with Praziquantel. [PDF]

Animals (Basel), 2023
Chen C, Zhou X, Guo Q, Lv C, Tang Y, Guo Q, Chen Y, Zhou K, Fu Z, Liu J, Lin J, Hong Y, Chen JH.   +12 more
europepmc   +1 more source